“An LC-MS/MS Method Development and Validation for the Quantification of Infigratinib in K2EDTA Human Plasma” (2024) International Journal of Pharmaceutical Sciences and Drug Research, 16(1), pp. 86–91. doi:10.25004/IJPSDR.2024.160112.